{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:03:54Z","timestamp":1792292634037,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":2514,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1186\/s13613-019-0604-x","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:02:56Z","timestamp":1574852576000},"page":"131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-9722","authenticated-orcid":false,"given":"Benjamin Jean","family":"Gaborit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Tessoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Anne","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Leturnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Khatchatourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Asseray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Garret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vourch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Marest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0010","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/cti.2014.3","article-title":"Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation","volume":"3","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Transl Immunol."},{"issue":"12","key":"10.1186\/s13613-019-0604-x_bb0015","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1186\/s13613-019-0604-x_bb0020","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1186\/s13613-019-0604-x_bb0025","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/cid\/ciu104","article-title":"Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae","volume":"58","author":"Novosad","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"3","key":"10.1186\/s13613-019-0604-x_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jcrc.2013.12.005","article-title":"Outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients","volume":"29","author":"Ko","year":"2014","journal-title":"J Crit Care"},{"issue":"8","key":"10.1186\/s13613-019-0604-x_bb0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"Festic","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0045","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit Care Lond Engl."},{"issue":"5","key":"10.1186\/s13613-019-0604-x_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002030-199105000-00008","article-title":"Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis","volume":"5","author":"Jensen","year":"1991","journal-title":"AIDS Lond Engl."},{"issue":"4","key":"10.1186\/s13613-019-0604-x_bb0055","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/JCM.03494-14","article-title":"Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia","volume":"53","author":"Lee","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3947\/ic.2018.50.2.110","article-title":"Low lymphocyte proportion in bronchoalveolar lavage fluid as a risk factor associated with the change from trimethoprim\/sulfamethoxazole used as first-line treatment for Pneumocystis jirovecii pneumonia","volume":"50","author":"Kim","year":"2018","journal-title":"Infect Chemother."},{"issue":"21","key":"10.1186\/s13613-019-0604-x_bb0065","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM199011223232103","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial","volume":"323","author":"Gagnon","year":"1990","journal-title":"N Engl J Med."},{"issue":"21","key":"10.1186\/s13613-019-0604-x_bb0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1186\/s13613-019-0604-x_bb0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","article-title":"Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia","volume":"113","author":"Pareja","year":"1998","journal-title":"Chest"},{"issue":"3","key":"10.1186\/s13613-019-0604-x_bb0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/598651","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients","volume":"29","author":"Delclaux","year":"1999","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"8","key":"10.1186\/s13613-019-0604-x_bb0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/342338","article-title":"Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study","volume":"35","author":"Zahar","year":"2002","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"5","key":"10.1186\/s13613-019-0604-x_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis."},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/ajrccm.160.2.9901019","article-title":"AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia","volume":"160","author":"Azoulay","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1186\/s13613-019-0604-x_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4187\/respcare.05500604","article-title":"Delivered oxygen concentrations using low-flow and high-flow nasal cannulas","volume":"50","author":"Wettstein","year":"2005","journal-title":"Respir Care."},{"issue":"23","key":"10.1186\/s13613-019-0604-x_bb0105","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"ARDS Definition Task Force","year":"2012","journal-title":"JAMA."},{"issue":"8","key":"10.1186\/s13613-019-0604-x_bb0110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/13693786.2010.484027","article-title":"Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection","volume":"48","author":"Iriart","year":"2010","journal-title":"Med Mycol"},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0115","first-page":"e140","article-title":"Hypersensitivity pneumonitis and alpha-chemokines","volume":"168","author":"Limongi","year":"2017","journal-title":"Clin Ter"},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0120","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/cc11247","article-title":"Risk factors for the development of acute lung injury in patients with infectious pneumonia","volume":"16","author":"Kojicic","year":"2012","journal-title":"Crit Care Lond Engl."},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0125","first-page":"59","article-title":"Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors","volume":"13","author":"Boonsarngsuk","year":"2009","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis."},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jinf.2014.02.015","article-title":"Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection","volume":"69","author":"Kim","year":"2014","journal-title":"J Infect"},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","article-title":"Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia","volume":"14","author":"Lemiale","year":"2013","journal-title":"Respir Res"},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0163-4453(03)00038-0","article-title":"Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study","volume":"47","author":"Roblot","year":"2003","journal-title":"J Infect"},{"issue":"4","key":"10.1186\/s13613-019-0604-x_bb0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/infdis\/jir302","article-title":"Alveolar and blood T lymphocyte profiles in Pneumocystis jirovecii-positive patients: effects of HIV status","volume":"204","author":"Iriart","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1186\/s13613-019-0604-x_bb0150","doi-asserted-by":"crossref","unstructured":"Azoulay E, Roux A, Vincent F, Kouatchet A, Argaud L, Rabbat A, et al. A multivariable prediction model for Pneumocystis jirovecii pneumonia in hematology patients with acute respiratory failure. Am J Respir Crit Care Med. 2018.","DOI":"10.1164\/rccm.201712-2452OC"},{"issue":"10","key":"10.1186\/s13613-019-0604-x_bb0155","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s00134-006-0286-3","article-title":"Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU","volume":"32","author":"Lamia","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-019-0604-x_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40560-018-0307-7","article-title":"The prognostic performance of qSOFA for community-acquired pneumonia","volume":"6","author":"Tokioka","year":"2018","journal-title":"J Intensive Care."},{"issue":"12","key":"10.1186\/s13613-019-0604-x_bb0165","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.5858\/arpa.2017-0115-SA","article-title":"Molecular and immune biomarkers in acute respiratory distress syndrome: a perspective from members of the pulmonary pathology society","volume":"141","author":"Capelozzi","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1186\/s13613-019-0604-x_bb0170","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/labinvest.3700440","article-title":"Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia","volume":"86","author":"Dhanireddy","year":"2006","journal-title":"Lab Investig J Tech Methods Pathol."},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/IAI.01189-15","article-title":"Treatment with interleukin-7 restores host defense against pneumocystis in CD4+ T-lymphocyte-depleted mice","volume":"84","author":"Ruan","year":"2015","journal-title":"Infect Immun"},{"issue":"2","key":"10.1186\/s13613-019-0604-x_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jiac.2013.09.004","article-title":"Pneumocystis polymerase chain reaction and blood (1\u2009\u2192\u20093)-\u03b2-d-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia","volume":"20","author":"Matsumura","year":"2014","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1186\/s13613-019-0604-x_bb0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/00365548.2013.865142","article-title":"Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment","volume":"46","author":"Roblot","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"11\u201312","key":"10.1186\/s13613-019-0604-x_bb0190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365540410021180","article-title":"Risk factors analysis for Pneumocystis jirovecii pneumonia (PCP) in patients with haematological malignancies and pneumonia","volume":"36","author":"Roblot","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1186\/s13613-019-0604-x_bb0195","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis."},{"issue":"6","key":"10.1186\/s13613-019-0604-x_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jirovecii pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol."},{"issue":"3","key":"10.1186\/s13613-019-0604-x_bb0205","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1186\/s13613-019-0604-x_bb0215","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"key":"10.1186\/s13613-019-0604-x_bb0220","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in patients with HIV infection","volume":"4","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1186\/s13613-019-0604-x_bb0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jiac.2014.03.003","article-title":"Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients","volume":"20","author":"Kofteridis","year":"2014","journal-title":"J Infect Chemother Off J Jpn Soc Chemother."},{"issue":"4","key":"10.1186\/s13613-019-0604-x_bb0235","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.07-0223","article-title":"Clinical picture of Pneumocystis jirovecii pneumonia in cancer patients","volume":"132","author":"Boll\u00e9e","year":"2007","journal-title":"Chest"},{"issue":"7","key":"10.1186\/s13613-019-0604-x_bb0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","article-title":"Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients","volume":"21","author":"Roblot","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol."},{"issue":"1","key":"10.1186\/s13613-019-0604-x_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","article-title":"Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17\u00a0years","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit Care Lond Engl."},{"issue":"Suppl B","key":"10.1186\/s13613-019-0604-x_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/37.suppl_B.33","article-title":"Pneumocystis carinii infection: current treatment and prevention","volume":"37","author":"Miller","year":"1996","journal-title":"J Antimicrob Chemother."}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-019-0604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13613-019-0604-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202501026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202501026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-019-0604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:34:53Z","timestamp":1776670493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S211058202501026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["S211058202501026X"],"URL":"https:\/\/doi.org\/10.1186\/s13613-019-0604-x","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-019-0604-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The Author(s) 2019. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"131"}}